Skip to content

Clinical trials

Neuroectodermal Tumors, Primitive, Peripheral trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroectodermal Tumors, Primitive, Peripheral Country / region: United States Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20019
20026
20033
20047
20057
20064
20076
20089
20091
20103
20111
20122
20133
20142
20151
20162
20178
20186
20203
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed85
Terminated10
Active, not recruiting9
Unknown status4
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)36
Children's Oncology Group16
Memorial Sloan Kettering Cancer Center9
City of Hope Medical Center6
National Institutes of Health Clinical Center (CC)5
Dana-Farber Cancer Institute3
Milton S. Hershey Medical Center3
St. Jude Children's Research Hospital3
Fred Hutchinson Cancer Center2
Gradalis, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroectodermal Tumors, Primitive, Peripheral111
Sarcoma79
Osteosarcoma62
Neuroblastoma55
Medulloblastoma38
Wilms Tumor37
Central Nervous System Neoplasms32
Rhabdomyosarcoma32
Astrocytoma23
Lymphoma, Non-Hodgkin21

Trials

Showing 26 to 50 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.